Share

June 2014; 1 (1) ArticleOpen Access

Predictors of recurrence following an initial episode of transverse myelitis

Dorlan J. Kimbrough, Maureen A. Mealy, Alexandra Simpson, Michael Levy
First published April 24, 2014, DOI: https://doi.org/10.1212/NXI.0000000000000004
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1707

Share

Article Information

vol. 1 no. 1 e4
DOI: 
https://doi.org/10.1212/NXI.0000000000000004
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received March 11, 2014
  • Accepted in final form March 17, 2014
  • First Published April 24, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Dorlan J. Kimbrough, MD,
    2. Maureen A. Mealy, RN,
    3. Alexandra Simpson, MS and
    4. Michael Levy, MD, PhD
  1. Dorlan J. Kimbrough, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consulting fees from Medical Logix, LLC for the development of continuing medical education programs.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Educational grant support from Teva Pharmaceuticals

    Research Support, Government Entities:

    1. National Institutes of Health T32 Training Program in Neuroinfectious Diseases and Neuroimmunology at Johns Hopkins University, 5T32NS069351-2, Fellow, 2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Maureen A. Mealy, RN,
    3. Scientific Advisory Boards:

    1. Served on an advisory board for Novartis Pharmaceuticals.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Alexandra Simpson, MS and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Michael Levy, MD, PhD
    5. Scientific Advisory Boards:

    1. Asterias

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Asterias, Guthy Jackson Charitable Foundation to present data

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. The Neurology and Psychiatry Work-Up (Patient Encounters), Lippincott Williams & Wilkins; 1 edition (December 1, 2009)

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. ApoPharma Inc., NeuralStem Inc., Viropharma (Shire), Sanofi, Genentech, Acorda

    Research Support, Government Entities:

    1. National Institute of Neurological Diseases and Stroke

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Guthy-Jackson Charitable Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Johns Hopkins University, Baltimore, MD.
  1. Correspondence to Dr. Levy: mlevy{at}jhmi.edu
View Full Text

Article usage

Article usage: April 2014 to February 2019

AbstractFullPdfSource
Apr 20145973353Highwire
May 2014141269129Highwire
Jun 2014883176165Highwire
Jul 20142854758Highwire
Aug 201419613635Highwire
Sep 20141044128Highwire
Oct 20142014435Highwire
Nov 20141327629Highwire
Dec 20148413423Highwire
Jan 20158410814Highwire
Jan 201504925pmc
Feb 201563766Highwire
Feb 201505328pmc
Mar 20158514815Highwire
Mar 201505829pmc
Apr 20158811132Highwire
Apr 201505033pmc
May 20154511929Highwire
May 201504121pmc
Jun 20156112527Highwire
Jun 201502920pmc
Jul 2015579124Highwire
Jul 201503921pmc
Aug 2015829813Highwire
Aug 201503115pmc
Sep 2015817912Highwire
Sep 201503110pmc
Oct 20152110412Highwire
Oct 201502517pmc
Nov 20154210910Highwire
Nov 201503119pmc
Dec 2015251268Highwire
Dec 201503518pmc
Jan 2016391276Highwire
Jan 201604015pmc
Feb 20162313422Highwire
Feb 201601712pmc
Mar 20163217515Highwire
Mar 201602220pmc
Apr 20162716410Highwire
Apr 201602013pmc
May 20164316517Highwire
May 201601712pmc
Jun 20163612510Highwire
Jun 20160185pmc
Jul 201615812114Highwire
Jul 20160133pmc
Aug 20163912311Highwire
Aug 20160189pmc
Sep 2016261066Highwire
Sep 20160156pmc
Oct 2016201417Highwire
Oct 20160145pmc
Nov 201613952Highwire
Nov 2016075pmc
Dec 2016101246Highwire
Dec 201601614pmc
Jan 2017161766Highwire
Jan 20170176pmc
Feb 2017101711Highwire
Feb 20170137pmc
Mar 20172223611Highwire
Mar 20170135pmc
Apr 2017161804Highwire
Apr 2017122223pmc
May 2017181634Highwire
May 201751111pmc
Jun 201762005Highwire
Jun 2017101822pmc
Jul 201763465Highwire
Jul 201731314pmc
Aug 2017273906Highwire
Aug 201783139pmc
Sep 2017123064Highwire
Sep 201742226pmc
Oct 2017113358Highwire
Oct 201731112pmc
Nov 2017173326Highwire
Nov 201772623pmc
Dec 20174774Highwire
Jan 20184918Highwire
Feb 20184875Highwire
Mar 2018933311Highwire
Apr 201833145Highwire
Apr 201811516pmc
May 201852608Highwire
Jun 201822226Highwire
Jun 201811920pmc
Jul 2018317810Highwire
Aug 201831466Highwire
Aug 201832530pmc
Sep 201801415Highwire
Oct 2018216612Highwire
Nov 2018820610Highwire
Dec 2018733314Highwire
Jan 20191022518Highwire
Feb 20191720113Highwire

Cited By...

Letters: Rapid online correspondence

Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.nn.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Letters

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Letters Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

  • No related articles found.

Alert Me

Advertisement